CIK 0001622229 · Large accelerated filer
Cogent Biosciences, Inc.
Sign in to watch- Ticker
- COGT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 465308248
- Phone
- 617-945-5576
- Business address
- 180 THIRD AVENUE, 4TH FLOOR, WALTHAM, MA
- Former names
- Unum Therapeutics Inc., Unum Therapeutics, Inc.
- 144 Insider Sale of Securities
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Chief Legal Officer sold 65,000 shares at $38.70 ($2,515,500)
- 4 Open-market sale Chief Financial Officer sold 77,000 shares at $38.68 ($2,978,360)
- 4 Open-market sale Chief Medical Officer sold 82,642 shares at $38.70 ($3,198,245)
- 4 Open-market sale Chief Scientific Officer sold 90,000 shares at $38.74 ($3,486,600)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Shares withheld for taxes Chief Scientific Officer gave up 139,998 shares (to pay taxes)
- 4 Shares withheld for taxes President and CEO gave up 367,497 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Commercial Officer gave up 94,800 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Legal Officer gave up 125,602 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Medical Officer gave up 154,716 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 145,007 shares (to pay taxes)
- 8-K Event Other events
Page 3 of 31 · 616 filings